Evidence map›Paper›PMID 35388303›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Exploring Active Compounds and Mechanisms of Angong Niuhuang Wan on Ischemic Stroke Based on Network Pharmacology and Molecular Docking.

Yasu Zhang, Xiaomin Liu, Junzi Long, Xue Cheng, Xinyu Wang, Xiaodong Feng

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Salsolinol improves angiotensin II‑induced myocardial fibrosisExperimental and therapeutic medicine · 2023
    Article
  7. Metabolomics: A useful tool for ischemic stroke research.Journal of pharmaceutical analysis · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yasu ZhangSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0003-1332-586X
Xiaomin LiuSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0002-4656-9302
Junzi LongSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0001-5620-7471
Xue ChengSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0002-7044-5852
Xinyu WangSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0002-9110-3931
Xiaodong FengSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.ORCID https://orcid.org/0000-0003-2716-1827

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods: The chemical ingredients of ANW were retrieved from TCMSP, TCMID, and literature. We predicted the potential targets of active ingredients by PubChem, Swiss Target Prediction, and STITCH databases. The targets related to ischemic stroke were retrieved using GeneCards, DisGeNET, DrugBank, TTD, and GEO databases. Subsequently, Venn diagrams were used to identify common targets of active ingredients and ischemic stroke. Protein-protein interaction (PPI) network was structured with STRING platform and Cytoscape 3.8.2. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of key targets were performed in the Metascape database. Finally, molecular docking was conducted by AutoDock Tools and PyMOL software. Results: A total of 2391 targets were identified for 230 active ingredients of ANW, and 1386 of them overlapped with ischemic stroke targets. The key active ingredients were mainly quercetin, Conclusion: In conclusion, the bioinformatics and pharmacological results reveal that counteracting oxidative stress, suppressing inflammation, inhibiting the development of AS, and even protecting neurological function are critical pathways for ANW in the treatment of ischemic stroke. These results may help to elucidate the mechanism of ANW on ischemic stroke for experimental studies and clinical applications.

Identifiers

PMID35388303
PMCPMC8977296

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.